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Abstract— Objective: The present study aimed to evaluate a 
new tibial nerve stimulation (TNS) modality, which uses 
interferential currents, in terms of the stimulation electric field 
penetration efficiency into the body and physiological 
effectiveness. Methods: In silico experiments were performed to 
analyze the penetration efficiency of proposed interferential 
current therapy (ICT). Based on this, we performed in vivo 
experiments to measure excitation threshold of ICT for the tibial 
nerve, which is related to stimulation field near the nerve. 
Regarding analysis of the physiological effectiveness, in vivo ICT–
TNS was performed, and changes in bladder contraction 
frequency and voiding volume were measured. The penetration 
efficiency and physiological effectiveness of ICT were evaluated 
by comparison with those of conventional TNS using 
transcutaneous electrical nerve stimulation (TENS). Results: 
Simulation results showed that ICT has high penetration 
efficiency, thereby generating stronger field than TENS. These 
results are consistent with the in vivo results that nerve excitation 
threshold of ICT is lower than that of TENS. Moreover, ICT–TNS 
decreased contraction frequency and increased voiding volume, 
and its performance was profound compared with that of TENS–
TNS. Conclusion: The proposed ICT is more efficient in inducing 
the stimulation field near the tibial nerve placed deep inside the 
body compared with conventional TENS and shows a good 
clinical effectiveness for TNS. Significance: The high efficiency of 
ICT increases the safety of noninvasive neurostimulation; 
therefore, it has clinical potential to become a promising modality 
for TNS to treat OAB and other peripheral neurostimulations. 
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I. INTRODUCTION 
VERACTIVE bladder syndrome (OAB) is a symptom of 
neurogenic bladder considered as a complex urinary 
urgency [1, 2]. OAB is a highly prevalent disease (the Current 
Bladder Dysfunction Reports estimated that approximately 16% 
of the population of the USA experience it [3]) that burdens 
patients with decreasing quality of life [4, 5]. This abnormal 
voiding reflex can be caused by either damage of the inhibitory 
central nervous system or sensitization of the peripheral system 
[6]. Antimuscarinic drugs, such as oxybutynin, are well known 
to effectively correct neurogenic abnormalities and are thus the 
dominant treatment for OAB. However, such drugs have side 
effects, such as low effectiveness or inhibition of other organs 
such as the mouth [7-9]. For patients who do not benefit from 
drug therapy, neurostimulation has been suggested, with 
proven clinical effects. Although sacral nerve stimulation (SNS) 
is the most common and main neurostimulation technique for 
OAB, some limitations have been reported, such as stimulator 
implantation issues [10]. 
Electrical tibial nerve stimulation (TNS) has been 
demonstrated as an effective, simple, low-risk alternative to 
SNS [11, 12]. The selected TNS site, located near the posterior 
ankle, is easily accessible compared with the surgery required 
for the neurostimulation method of SNS [13-15]. Two TNS 
stimulating strategies are known: invasive and noninvasive 
methods. Noninvasive TNS using skin-attached electrodes is 
safer and more convenient than the invasive method requiring 
needle insertion [16]. The widely used method for noninvasive 
TNS is transcutaneous electrical nerve stimulation (TENS).  
However, conventional TENS method exhibits poor 
penetration efficiency of the stimulation electric field because 
TENS generates extremely low inner-body field intensity 
compared with its strong near-skin field. The low penetration 
efficiency of TENS may result in common stimulation side 
effects, such as skin redness, burn, or an undesired sensation 
such as pain [17]. This is because the low penetration efficiency 
of TENS hampers the stimulation current flowing inside the 
body, resulting in most of the stimulation energy being 
attenuated proximal to the skin. To mitigate this safety burden, 
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the stimulation intensity can be lowered; however, such 
lowering may compromise the clinical effectiveness. 
To overcome the aforementioned limitations and achieve a 
high penetration efficiency, in the present study, we propose a 
new strategy for noninvasive TNS based on interferential 
current therapy (ICT), thereby providing high-field penetration 
efficiency and minimizing attenuation in the subcutaneous area 
[18, 19]. ICT has been considered only as a focusing modality 
for electrical stimulations; however, it has a better potential for 
improving the field penetration efficiency using high frequency 
carrier signals. Grossman et al. [20] reported on this potential 
of ICT by applying it to the brains of mice. However, we 
believe that ICT can maximize its benefits for peripheral nerve 
stimulation applications, such as TNS, rather than brain 
stimulation, where regions that are too deep are targeted. To 
quantitatively analyze our pioneering approach toward ICT, we 
performed extensive computational analysis of the field 
penetration efficiency of ICT. The corresponding animal 
experiments measured the nerve excitation ability of ICT, 
which is strongly related to the field generated near the nerve. 
With regard to the physiological performance of ICT, we 
practically demonstrated the physiological effectiveness of ICT 
by performing in vivo experiments measuring change in 
bladder activity after ICT–TNS. Furthermore, we evaluated the 
field penetration efficiency and physiological effectiveness of 
ICT by comparing them with those of TENS. 
II. METHODS 
A. Concept of ICT for Noninvasive Neuromodulation 
The electrical impedances in body tissue decrease as the 
frequency of applied external current increases; consequently, 
the penetration depth of applied current becomes deeper and the 
induced field inside the body increases. The conventional 
TENS methods utilize low-frequency current, ultimately 
resulting in the inherent low-penetration issue. Moreover, 
currents induced by the TENS spread on the body from the 
source, exhibiting poor localization for the stimulation. The 
ICT method overcomes this issue using the 
amplitude-modulation of high-frequency signals. Applying 
high-frequency signals that differ only by a slight frequency 
level (e.g., 𝑓1 = 2 kHz, 𝑓2 = 2.01 kHz), a low-frequency beat 
envelope ( Δ𝑓 = 𝑓1 − 𝑓2 = 10 Hz ) is created by current 
interference. If the beat frequency is sufficiently low for 
neurons to respond, interfering currents can then evoke the 
nervous system as pure low-frequency stimulation [21, 22]. 
The high-frequency ICT carrier facilitates penetration, and its 
low-frequency envelope facilitates substantial nerve 
stimulation. In other words, the high-frequency modulated by 
the ICT has the simultaneous advantages of avoiding the body 
impedance effect and evoking the nervous system. 
 
B. Waveform Design for ICT and TENS 
Waveform parameters for TENS and ICT are as follows: (1) 
TENS (200-µs pulse width/10-Hz frequency/square waveform), 
(2) ICT (2 kHz + 2.01 kHz double sources). These parameters 
of TENS were reportedly effective in bladder inhibition and 
useful in treating OAB [12, 23, 24]. The 2-kHz carrier 
frequency for ICT stimulation was selected by benchmarking a 
research demonstrating the effectiveness of ICT from a neuron 
cell to the brain tissue level [20]. The 10-Hz beat frequency of 
ICT was chosen to match the stimulation frequency of TENS. 
Therefore, using these parameters, we justified a fair 
comparison between the proposed ICT–TNS method and the 
clinically applied TENS–TNS method in the real world. 
Fig. 1 shows the conceptual waveform difference between 
ICT and TENS. Phase synchronization of ICT at 50 and 150 ms 
showed positive interference, and desynchronization at 0, 100, 
and 200 ms showed negative interference. The 100-ms period 
(= 10 Hz) envelope signal by the interferences of ICT can 
stimulate the nervous system and elicit a neural response. In 
contrast, although TENS typically comprises zero intensity 
signal, short pulses appear at 100 and 200 ms. The stimulation 
period of TENS and ICT is 100 ms; however, the ICT 
waveform uses the full time of 100 ms for stimulation, whereas 
the TENS waveform uses only 200 µs of 100 ms for the same 
stimulation. 
 
C. Simulation Platform Validation (Phantom Experiment) 
A biomedical electromagnetic simulator (Sim4Life, Zürich 
MedTech AG) was used to predict the EM field distribution on 
an in vivo tissue. Prior to its use, the simulator was extensively 
validated via in vitro measurements. 
 
 
Fig. 1. Waveform and stimulation modality differences between TENS and 
ICT. TENS has a 200-µs pulse width and 10-Hz frequency. ICT has a −2-kHz 
carrier frequency and 10-Hz interfering (envelope) frequency (Src 1: 2 kHz, 
Src 2: 2.01 kHz). Unlike TENS, ICT utilizes the 100-ms envelope gnerated by 
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1) Electromagnetic Simulation Theory 
From the electroquasistatic assumption, 
 
 𝐸 =  −∇𝜙. (1) 
 
We can solve Laplace’s equation under the Dirichlet 
constant voltage boundary condition without the source 
current: 
 
 ∇ ⋅ [(𝜎 + 𝑗𝜔𝜀) ∇ 𝜙] = 0, ( ∵ 𝐽source = 0), (2) 
 
where 𝜀  is the permittivity, 𝜎  is the effective (equivalent) 
electrical conductivity, and 𝜔 is the angular frequency [25, 26]. 
The potential for each voxelized element with the finite element 
method was obtained by solving Eq. (2) and the corresponding 
electric field was calculated by Eq. (1). 
 
2) Phantom Fabrication 
Fig. 2(a) shows a 78-mm radius plastic container (M2R-CL, 
VisiJet® ) with a 4 × 4 cylinder array, fabricated as a phantom 
design using a 3D CAD tool (SolidWorks, Dassault Systèmes 
SOLIDWORKS Corp.). Overall, 16 cylinders with 1-cm 
diameter were placed at every 2 cm. Four point-voltage 
recording electrodes were placed at the four cardinal directions 
(left, right, top, and bottom) of each cylinder. Two 
square-shaped stimulating stainless-steel electrodes (1 × 1 cm) 
were positioned on the circumference of the container at a 45° 
angle to be fully soaked. The container was filled with a 0.9% 
NaCl physiological saline solution [27]. The conductivity of the 
filing solution was 𝜎  = 1.7 S/m, as measured using a 
conductivity meter (YK-43CD, Lutron). 
3) In Vitro and In Silico Phantom Experiments 
For phantom experiments, a constant voltage of 3.04 V at 
1 kHz was applied using a waveform generator (33220A, 
Agilent) between the stimulating electrodes. The effective load 
voltage was directly measured through an oscilloscope (DPO 
3032, Tektronix) to compensate for the impedance matching 
errors. Fig. 2(b) presents the experiment’s schematic 
measurement system. For each cylinder, four voltage values 
were measured from each recording electrode using a 
differential voltage DAQ system (NI 9220, National 
Instruments). The four measured values were averaged after 
acquisition and total 16 voltage values per cylinder were 
obtained. 
For simulation, the 3D CAD file of the phantom was 
imported into the simulator. Virtual stimulating electrodes were 
placed at the same location as in the in vitro experiments. The 
container body’s conductivity was set as the ideal perfect 
dielectric of 0 S/m. The filling solution was assigned a 
conductivity of 1.7 S/m and a relative permittivity of 𝜀𝑟 = 76.5, 
which corresponds to measured saline conductivity and water 
permittivity. The constant voltages of 3.04 V and GND were 
applied to the stimulating electrodes. To estimate the open 
space, zero paddings and 0 V were applied on the outside 
boundary. 
 
D. In Silico TENS and ICT Experiments 
3D human and rat anatomical models were imported into the 
simulator with the parameters shown in Table I [28, 29]. The 
ICT and TENS stimulators were compared in terms of electric 
field distribution. The 26-year-old Korean female model 
Yoon-sun cV3.1, constructed with magnetic resonance imaging 
and computed tomography images, was used as the human 
model [30, 31]. A big male rat (Sprague–Dawley, 567 g) was 
used as the rat model [32]. Fig. 3 shows the virtual electrodes 
positioned for each TENS and ICT in the rat and human models 
(see Fig. 13). For the rat model, the size of the electrodes was 
2.5 mm wide × 2.5 mm long × 1 mm high. The conductive gel 
had the same width and length of the electrodes but the 
 
 
Fig. 2. (a) 3D modeled (left) and fabricated phantom (right). (b) Schematic 






























Conductivity σ (𝑆/𝑚) Relative Permittivity 𝜀𝑟
a 
Airb 0 1 
Skin 2  10-4 1136 
Fat 1.2207  10-2 7.9735  106 
Muscle 0.20197 2.57  107 
Blood 0.7 5260 




Conductivity σ (𝑆/𝑚) Relative Permittivity 𝜀𝑟
a 
Air 0 1 
Skin 2.0023  10-4 1135.3 
Fat 2.3048  10-2 10308 
Muscle 0.32953 168020 
Blood 0.7 5257 
Gel 0.6 76.5 
aThe relative permittivity 𝜀𝑟 = 𝜀/𝜀0. 
bBackground 
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thickness of gel ranged from 0.5 to 2 mm due to uneven surface 
of the skin. For the human model, the electrode size was 1 cm 
wide × 1 cm long × 1 mm high and the gel thickness ranged 
from 0.5 to 1 cm. 
For TENS modeling, a single source consisting of two 
stimulating electrodes was vertically placed on the posterior 
part of the right ankle. A conductive gel was placed between 
each electrode and the skin. Tissue conductivity, which 
depends on the operating frequency, was set at 10 Hz, which is 
known to inhibit the micturition reflex (MR) [23, 33, 34]. The 
load voltage between electrodes was 10 V. The outside 
boundary was set to 0 V/m with the Neumann condition. The 
simulated electric field was extracted as a result. Specifically, 
the electric field along the 𝑧-axis (Ez), which is parallel to the 
tibial nerve spreading, was selected because nerves are more 
sensitive to parallel field than to orthogonal field [35]. 
For ICT modeling, four different electrodes were positioned 
near the ankle, allocating two electrodes per source. Tissue 
parameters were set at a 2 kHz frequency (because 2 kHz and 
2.01 kHz are nearly similar). After simulating each source, the 
effective interfering envelope intensity of 10 Hz frequency was 




𝐸𝑧𝑒𝑛𝑣 = 2 min(|𝐸𝑧1|, |𝐸𝑧2|) 
= ||𝐸𝑧1 + 𝐸𝑧2| − |𝐸𝑧1 − 𝐸𝑧2||, 
(3) 
   
where 𝐸𝑧1 and 𝐸𝑧2 are the 𝑧-axis electric field components of 
each source. 
E. Stimulation Thresholds of TENS and ICT 
1) Concept of Stimulation Threshold 
To quantitatively assess the nerve excitation ability of a 
noninvasive stimulation modality, we introduce the concept of 
stimulation threshold, which is defined as the minimum 
stimulus intensity for the occurrence of nerve excitation. 
Therefore, a higher stimulation threshold indicates that it is 
more difficult for the noninvasive stimulation to induce nerve 
excitation. 
2) Stimulation Threshold for the Tibial Nerve 
The anatomical connection between the tibial nerve and 
hallux muscle induces motor actions, such as toe tremor, when 
the tibial nerve is effectively evoked due to stimulation. This 
acute motor response of hallux during TNS is a good clinical 
indicator of excitation of the tibial nerve due to noninvasive 
stimulation [23]. 
3) In Vivo Measurement of Stimulation Threshold 
In vivo experiments were performed on rats sampled from 
the population described above (6 male Sprague–Dawley rats) 
to compare the stimulation threshold between TENS and ICT. 
Under isoflurane anesthesia at 2.5% and O2 rate at 0.7–0.9 
L/min, the lower leg near the posterior ankle was shaved using 
a fur trimmer and shaving cream. Thereafter, the 
abovementioned stimulating electrodes were attached using a 
conductive gel to the posterior ankle at the same place with the 
simulation modelling. Both stimulation inputs of TENS and 
ICT were voltage driven. 
 
F. In Vivo TNS with ICT and TENS 
1) Customized ICT Stimulator System 
Fig. 4(a) illustrates the operation diagram of a customized 
ICT stimulator with a current driven circuit. The frequency and 
current amplitude were controlled using a PC via a customized 
program (LabVIEW, National Instruments). The output current 
ranged from 0.1 to 4.4 mA at a voltage bound of ±24 V. 
2) Bladder Catheterization 
All procedures were approved by the Pohang University of 
Science and Technology Institutional Animal Care and Use 
Committee (POSTECH IACUC) for male Sprague–Dawley 
rats (weight: 250–300 g, just one subject weighed 180 g). For 
bladder implantation, isoflurane 5%, at a rate of 0.5–0.6 L/min, 
 
Fig. 3. 3D rat model used for in silico rat experiments. Stimulating electrodes 
for TENS and ICT were placed near the posterior ankle. The electrodes were 






Fig. 4. Systemic illustrations of in vivo rat experiments of noninvasive TNS 
with ICT. (a) Diagram of a customized ICT stimulator. (b) Experimental 
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was used for short acute anesthesia (2-3 min), after which 
isoflurane 2% was maintained during surgery (0.5–1 h). Prior to 
surgery, the rats’ abdominal fur was shaved using a hair 
trimmer and a depilatory cream. The skin was disinfected using 
isopropyl alcohol (IPA) and povidone. A PE50 tube was 
catheterized into the bladder, passed under the skin, and 
retrieved near the neck. Success of the surgery was confirmed 
by injecting a 0.9% saline solution through the tube and 
checking whether it emerged of the urethra without leakage. 
The bladder, muscle, and skin were sutured with braided silk 
(W593 for bladder and muscle, W529H for skin, Ethicon). 
3) Experimental System 
Fig. 4(b) visually describes the experimental setup for pre- 
and post-ICT stimulation bladder activity monitoring. 
Immediately after surgery, isoflurane was discontinued and 
urethane (1.0–1.2 g/kg) was injected because isoflurane shows 
higher MR suppression than urethane [36]. Two half-doses 
were intraperitoneally injected at 30-min intervals [37]. Upon 
the occurrence of waking-up signs, a dose of 0.5–1.5 g/kg of 
urethane was supplemented. For cystometry, the tube pulled 
out of the subjects’ neck was connected to a constant infusing 
syringe pump (Legato®  210P, KD Scientific) and a pressure 
transducer (IX-RA-834, iWorx). A 0.9% saline solution was 
continuously infused (100 μL/min) into the bladder via the 
catheter, and the subjects were placed on a plate with a urine 
hole. Urine droplets were naturally collected via the hole onto a 
Petri dish placed on an electrical scale (HS5002, Hansung 
Instrument Co.). Bladder pressure and urine weight were 
continuously transferred to the PC (10 samples/s for the 
pressure and 0.5 samples/s for the weight). The stimulating 
electrodes were customized with lead corresponding to the size 
of the simulation modelling, and they were placed at the same 
position with the simulation. Two customized ICT current 
sources were attached with a conductive gel (σ = 0.6 S/m) on 
the posterior ankle in a location similar to that in the rat 
simulation model. Current Source 1 used 2 kHz and Current 
Source 2 used 2.01 kHz, which made a 10 Hz interfering beat 
frequency. 
4) Experimental Protocol 
Under anesthesia and solution infusion, the bladder pressure 
and accumulated urine weight were continuously recorded 
before stimulation. If passive leakage occurred, indicating 
abnormal urine discharge caused by the MR suppression due to 
anesthesia, we waited 0.5–3 h for the disappearance of the 
suppression. The same constant current was applied to each 
source, and the current intensity was applied at the level of 
motor response signs, such as lower leg movement or toe 
tremor. Stimulation was maintained for 10 min but was 
withdrawn 30 min after the occurrence of issues such as 
inappropriate electrode adhesion or when the leg and toe motor 
signs were too weak. Poststimulation recording was maintained 
for 0.5–1 h to monitor both the bladder pressure and volume. 
Before each stimulation, we confirmed that the poststimulation 
effect totally disappeared and reverted to the prestimulation 
level to remove the cumulative effect. 
5) Analysis 
The average bladder contraction frequency [aBCF, 
Contractions/second (C/s)] and average voiding volume (aVV, 
mg) were used to compare pre- and poststimulation bladder 
activity and to evaluate the stimulating effect of ICT [13, 33, 
37]. aBCF was calculated as the number of peaks (5–15 peaks) 
per time interval between the first and last pre- and 
poststimulation peaks. aBCF excluded irregulars, such as 
chaotic peaks, occurring immediately after stimulation (1–10 
peaks). Spontaneous contraction peaks indicating nonvoiding 
contractions were removed by synchronizing the bladder 
pressure with the cumulative urine weight graph representing 
the actual voiding activity [38]. The aVV averaged the urine 
weight per micturition before and after stimulation (5–15 
micturition before and after stimulation, except for the chaotic 
irregulars). The mean ± standard deviation values of both aBCF 
and aVV before and after stimulation were visualized in bar 
plots with line graphs connecting each match of “before” and 
“after” raw data. Wilcoxon’s test was used to analyze the 
statistical difference between the pre- and poststimulation 
groups. The post-processing analysis and visualization were 
performed using MATLAB R2017a. 
6) Conventional TNS with TENS (Control Group) 
To evaluate the physiological effects of ICT–TNS proposed 
in this study, in vivo experiments with conventional TENS–
TNS generated by a TENS waveform generator (TPD-NH1, Nu 
Eyne) were performed as a control group. Bladder pressure and 
voiding volume were recorded using the Powerlab 8/30 system 
(ADInstruments). The remaining procedure was the same as the 
above protocols for the experiment using ICT–TNS. 
 
III. RESULTS 
A. Simulator Validation with In Vitro Phantom Experiments 
Fig. 5 presents the results of in vitro validation. To 
demonstrate that our simulation framework reflected the 
 
 
Fig. 5. Simulator validation with in vitro phantom experiments. (a) The 
simulated voltage distribution in 3D phantom model. Each circle indicates the 
centers of 16 cylinders. (b) and (d) Selectively extracted and normalized 
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real-world physical environment, the computed distribution of 
electrical potential was compared with the in vitro 
measurement. Two stimulation electrodes were placed on the 
right side of the phantom’s boundary circle, horizontally 
symmetric. The lower electrode was set as GND with voltage of 
0 V. From the 3D simulation data, a 2D plane where the voltage 
point electrode is located in the real phantom was selected as in 
Fig. 5(a). The square region in Fig. 5(b) was extracted from the 
simulation data to compare with the in vitro measured data. The 
voltage distribution was compared by normalizing both the 
simulated and measured data with the maximum and minimum 
value of both experiments. Fig. 5(c) and 5(d) visualize both 
normalized data. In both, the top-right corner has the highest 
value, whereas the bottom-right corner has the lowest value. 
Both the in silico and in vitro results show the same voltage 
distribution tendency, which is adequate for validation. 
 
B. In Silico Animal Experiments 
Fig. 6 describes the results of the simulation with the 3D rat 
model comparing TENS and ICT for TNS. The top of Fig. 6 
shows a side view of the model’s lower leg. The vertical and the 
horizontal lines designate the locations of a transverse and 
coronal plane, where the simulated electric field distribution 
was analyzed. Fig. 6(a) illustrates TENS and Fig. 6(b) 
illustrates ICT. In both, the right panels represent the Ez 
linearly scaled from 0 to 1.6 V/m on the coronal plane and the 
left panels show the Ez from 0 to 3 V/m on the transverse plane. 
In the coronal plane, the distribution of Ez of both TENS and 
ICT have substantial intensities along the 𝑧-axis in a 10-mm 
range. Along the 𝑦-axis, the difference between the two results 
was remarkable. The Ez distribution of TENS spreads widely 
and almost uniformly, whereas the distribution of ICT was 
specifically focalized inside the deep region. 
In the transverse plane, TENS showed that Ez spreads widely, 
as shown in the coronal plane with high intensity surrounding 
the stimulation electrodes and skin, which falls sharply after 
passing the near-skin. On the other hand, ICT shows relatively 
low field intensity loaded on the near-skin area compared with 
TENS. Along the 𝑦-axis, a long and narrow band was observed 
that smoothly penetrated from the skin into the inner-body 
region. The width of the band was <2 mm, demonstrating the 
focalized tendency of ICT. As a result, ICT passed inside the 
body without loading an excess of high field on the skin as well 
as spatially focusing its field. 
 
Fig. 7 shows data sampled from the focused band of the ICT 
and TENS-induced fields on the transverse plane. The location 
of the sample data is marked with the black dashed line in Fig. 6. 
The TENS has an extremely high near-skin field and extremely 
low inner-body field, whereas the ICT shows not much lower 
near-skin field intensity but higher inner-body field than TENS 
(see Fig. 7(a)). The inner-body field difference between TENS 
and ICT is more remarkable in logarithmic scale, as shown in 
Fig. 6(b). The ICT field intensity is approximately 1.56 times 
higher than that of TENS near the tibial nerve (5-mm deep 
under the skin). Fig. 6(c) presents that the relative electric field, 
based on the near-skin field, is considerably larger for ICT than 
for TENS. The ICT field maintained >90% intensity near the 
tibial nerve compared with that near the skin, whereas the 
 
 
Fig. 6. In silico rat experiments comparing ICT with TENS. Top figure 
illustrates the lower leg of the rat model and slices in transverse and coronal 
planes. (a) Ez (𝑧-axis electric field) distribution of TENS on the coronal plane 
(left) and on the transverse plane (right). (b) The Ez of ICT on the coronal 

































































































Fig. 7. Line sampled Ez data of TENS and ICT rat simulation results. Dashed 
line stands for TENS and solid line for ICT. Skin area is painted with gray 
color. (a) Linear scale E-field; (b) Logarithmic scale E-field; and (c), Relative 
E-field based on the field just beneath the skin 
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TENS field reduced to 20%. Moreover, ICT has its maximum 
field inside the body and not near the skin due to the focusing 
property. 
C. In Vivo Animal Experiments 
1) Comparison of Stimulation Threshold between ICT and 
TENS 
Fig. 8(a) illustrates the differences in the stimulation 
threshold between TENS–TNS and ICT–TNS for tibial nerve 
excitation (𝑛 = 18 for each group). The results were plotted in 
bar plots with standard deviation. For TENS, the stimulation 
threshold was 10.7 ± 3.80 V (mean ± standard deviation). For 
ICT, the threshold was 6.4 ± 1.5 V. Therefore, the mean of
 
stimulation threshold for ICT–TNS was approximately 1.67 
times lower than that for TENS–TNS (𝑝 < 0.001). Fig. 8(b) 
plots the XY distribution of the stimulation thresholds of TENS 
and ICT. The least square regression line of the data has much 
smaller slope (0.38) than the Y=X baseline (slope: 1). 
Furthermore, the coefficient of determination (𝑅2) between the 
stimulation thresholds of TENS and ICT was 0.8973.  
 
2) Rat Cystometry with the ICT for TNS 
Experimental data of bladder pressure and voiding volume 
were obtained from 8 out of 9 rats. Data from 1 rat were 
excluded because of unknown bladder pressure pattern with 
continuously increasing baseline. Fig. 9 shows the 
representative bladder pressures and voiding volumes 
measured during pre- and poststimulation. Fig. 9(a) shows 
sampled data of pressure for 13 MR peaks, and Fig. 9(b) shows 
the corresponding cumulative voiding volume. In both figures, 
the upper graph represents the prestimulation data, whereas the 
lower graph represents the poststimulation data. An MR period 
was defined as an interval between two continuous peaks. 
Starting from the first peak, there were 12 peak-to-peak 
 
 
Fig. 8. Comparison of stimulation thresholds of TENS and ICT. (a) Bar plots 
of voltage stimulation thresholds of TENS and ICT. Black dots present raw 
data. (b) XY plot of the thresholds of TENS and ICT. Dashed gray line 
indicates that the TENS and ICT thresholds are the same. Black solid line is 
the least square regression line of the data. (Unpaired t−test for (a), ***𝒑 < 















































Fig. 9. Continuous bladder pressure and cumulative voiding volume before 
and after ICT stimulation on the posterior ankle of rats. (a) Bladder pressure 
monitoring for 13 periods of micturition reflexes (urination). (b) Voiding 
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Fig. 10. Mean bladder contraction frequency (aBCF) and mean voiding 
volume (aVV) for pre- and poststimulation of ICT. (a)−(b) Bar plots (mean ± 
standard deviation) of aBCF and aVV before and after ICT stimulation; (a) 
aBCF, (b) aVV. Black dots present raw data. (c)−(d) Percentile changes of 
aBCF and aVV after stimulation; (c) aBCF, (d) aVV. Full data set is 
superimposed in gray. Mean and standard deviation of the changes are 
covered in black. (Wilcoxon signed-ranked test for (a) and (b): **𝒑 < 0.01, ***𝒑 































































TABLE II  
AVERAGE BLADDER CONTRACTION FREQUENCY AND AVERAGE VOIDING 
VOLUME IN PRE AND POST STIMULATION 
 
n = 19 
aBCF 
Mean ± std. mean of change 
Pre 13.2 ± 6.3 mC/s 
−16.8 % 
Post 11.1 ± 5.7 mC/s 
 
n = 15 
aVV 
Mean ± std. mean of change 
Pre 135 ± 94 mg 
7.38 % 
Post 178 ± 14 mg 
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intervals. The prestimulation pressure lasted for approximately 
15 min of the total 12 periods, and the corresponding volume 
was approximately1.3 g. After stimulation, the total time was 
about 20 min and the total volume was approximately 2.2 g. 
The aBCF decreased from 14 to 9 mC/s, and the aVV increased 
from 110 to 180 mg. The change in aBCF and aVV was −36% 
and 72%, respectively. 
For all experiments, Table II shows the mean aBCF (𝑛 = 19) 
and aVV (𝑛 = 15) with standard deviation and mean of change 
between pre- and poststimulation in aBCF and aVV. The lack 
of four aVV samples compared to aBCF was due to 
instrumental issues from the first 3 rats. The mean of aBCF 
decreased by approximately 17%, and that of aVV increased by 
approximately 7%. Fig. 10 complements the table with raw data 
and statistical analysis. Fig. 10(a) and 10(c) represent that the 
aBCF decrease is meaningful (𝑝 < 0.001), ranging from −0.94% 
at least to −50% at most. Fig. 10(b) and 10(d) represent that an 
aVV increase is also verified (𝑝 < 0.01), ranging from −2.3% to 
72%. 
Fig. 11 shows other observed bladder activity changes 
caused by TNS with ICT. Fig. 11(a) and 11(c) show that MRs 
were lost during or after stimulation. These are characterized as 
increasing the bladder pressure baseline and deleting the 
contraction peaks strictly related to passive leakages. In Fig. 
11(b), the contraction peak amplitudes were reduced during the 
stimulation phase. These irregular changes were observed from 
only one sample thorughout the entire experiment. 
 
3) Comparison of Rat Cystometry between ICT and TENS 
Fig. 12 presents a comparison between the physiological 
effects of ICT (experimental group) and TENS (controlled 
group), illustrating the difference in changes in physiological 
bladder activity between TENS–TNS and ICT–TNS in terms of 
aBCF and aVV (𝑛 = 10 for aBCF and aVV of TENS, 𝑛 = 19 for 
aBCF of ICT and 𝑛 = 15 for aVV of ICT). Fig. 12(a) shows a 
slight difference in the median of change in aBCF between ICT 
(−12.7 %) and TENS (−11.0 %) (𝑝 = 0.226). For the change in 
aVV shown in Fig. 11(b), the overall distribution of ICT was 
located higher than that of TENS as well as the median of aVV 
changes of ICT (+22 %) was higher than that of TENS (+7.1 %) 
(𝑝 = 0.068). 
 
D. In Silico Human Experiments 
Fig. 13 shows an overview of the in silico human model 
simulation results. Fig. 13(a) illustrates the positions of 
stimulating electrodes for TENS and ICT, and the location of 
the tibial nerve on cross-sectional views of coronal and 
transverse planes. The planar graphs in Fig. 13(b) and (c) are on 
the coronal and transverse planes and illustrate the calculated 
distributions of Ez of the TENS. The graphs of Fig. 13(d) and (f) 
are on the same plane but illustrate the distribution of Ez of the 
ICT. In the coronal plane (Fig. 13(b) and (d)), the overall 
distribution of Ez of ICT shows a stronger and focused intensity 
than that of TENS. The transverse plane of TENS in Fig. 13(c) 
shows a widely spread and extremely strong Ez around the skin, 
and it is sharply dissipated as penetrating inside the body. 
However, ICT generates a comparatively focused band and 
transfers the electric field to deeper regions without 
considerable dissipation (Fig. 13(e)). Therefore, the inner-body 
electric field generated by ICT around the tibial nerve is 
stronger than that generated by TENS. 
Sampled data from the simulation results clearly differentiate 
the inner field intensity of TENS and ICT (Fig. 13(f)). For 
sampling, line data were extracted along the gray dashed lines 
in Fig. 13(c) and (e), penetrating from the near-skin surface to 
inner-body deep region. The location of the tibial nerve is 
marked with black circle on the lines. TENS has near-skin 
intensity of 7.0 V/m, whereas the intensity of ICT is 
approximately 1.1 V/m, which is considerably lower than that 
of TENS. However, the near-tibial field (inner-body field) 
intensity of ICT is higher than that of TENS. In particular, the 
ICT has the highest value inside the body and not in the 
superficial region. In contrast, the TENS field is much stronger 
than the ICT in the superficial region. However, the TENS 
intensity reduced to 0.62 V/m and the ICT intensity slightly 
 
 
Fig. 11. Other observed changes in bladder pressure after ICT stimulation. 
Unclassified observations of change in bladder pressure after ICT stimulation. 
(a) Passive leakage occurred during the stimulation. (b) Reduced contraction 
pressure amplitude during the stimulation. (c) Passive leakage occurred during 








































Fig. 12. Comparison of bladder activity changes after TENS and ICT. (a)−(b) 
Boxplots of poststimulation-induced bladder activity change of TENS and 
ICT; (a) Percentile changes in aBCF, (b) Percentile changes in aVV. Black 
dots present raw data. (Unpaired t−test, 𝒏 = 10 for TENS in both of (a) and (b), 
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decreased only to 0.85 V/m at the tibial nerve. The intensity 
difference between TENS and ICT was more clearly illustrated 
in logarithmic scale as shown in Fig. 13(g). Fig. 13(h) presents 
the relative value of the inner-body field at the tibial nerve over 
the near-skin field. Compared with the near-skin field, the 
inner-body field intensity of TENS decreased to 20% but the 
ICT intensity decreased only to 80%. ICT intensity was its 
maximum not near the skin but inside the body 
IV. DISCUSSION AND CONCLUSION 
The proposed ICT modality is similar to the conventional 
TENS in that both methods are based on noninvasive 
transcutaneous delivery of electric fields for nerve stimulation. 
However, their field penetration efficiencies are quite different 
because the ratio of inner-body field to near-skin field 
generated by ICT is considerably higher than that generated by 
TENS. This is because the electrical impedance of the 
subcutaneous tissue is much lower at the carrier frequency of 
ICT than at that of TENS (which is technically direct current). 
Although high-frequency signals are filtered by neuron 
membranes, ICT can successfully cause stimulation and elicit 
physiological response using the low-frequency beat envelope. 
We evaluated and verified the field penetration efficiency and 
physiological effectiveness of ICT and compared their 
performances with conventional TENS applied for OAB 
treatment. 
In vivo measurements of inner-body field relative to 
near-skin field comprise the best and most direct way to 
evaluate the field penetration efficiency. However, this requires 
the insertion of recording electrodes into tissues, causing severe 
damage and electrical parameter distortion. In addition, 
conventional analytical calculation is almost impossible due to 
the complex heterogeneity of body tissues. Therefore, we used 
a 3D in silico model to characterize and analyze the difference 
of field penetration efficiency between the ICT- and 
TENS-induced electric fields. Before using the simulation 
framework for prediction, we extensively validated the 
computational model in vitro by showing the excellent 
agreement between the measured and simulation results (Fig. 
5). 
The in silico experiments showed a distinctly high 
penetration efficiency of ICT because the relative value of the 
field near the tibial nerve to the field near the skin was 
extremely high (Fig 7 and 13). In contrast, TENS showed 
extremely low penetration efficiency with much smaller 
relative value than that showed by ICT. The difference in their 
penetration efficiencies permitted for ICT to load less energy 
near the skin for the same level of tibial nerve recruitment with 
TENS. In other words, compared with TENS, ICT could 
transfer a stronger field to the tibial nerve deep inside the body 
with less power attenuation near the subcutaneous area. This 
implies that ICT–TNS shows more efficient penetration into 
the body deep near the tibial nerve as well as mitigates the 
skin-related safety issue of TENS–TNS. 
 
Fig. 13. In silico human experiments comparing ICT and TENS. (a) 3D human model with stimulating electrodes for TENS and ICT on the posterior ankle. 
Location of the tibial nerve is marked in cross-sections of a coronal and a transverse plane. (b) Distribution of Ez generated by TENS on the coronal plane, and (c) 
on the transverse plane. The black circle points the position of tibial nerve. (d) Ez distribution by ICT compared to TENS on the coronal plane, and (d) on the 
transverse plane. (f) & (g) Linear and logarithmic scale graphs of line sampled Ez data along the dashed line of (c) and (e). (h) Relative Ez based on each maximum 
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Subsequent in vivo experiments measuring the stimulation 
thresholds of ICT–TNS and TENS–TNS showed that the ICT 
modality has much lower threshold to evoke and stimulate the 
tibial nerve than that of TENS (Fig. 8). The mean stimulation 
threshold of ICT–TNS was 1.67 times lower than that of 
TENS–TNS, which is plausibly related to the mean simulation 
result that the electric field of ICT was 1.56 times higher than 
that of TENS. The results demonstrated that ICT can transfer 
the stimulation field to the inner-body nerve 1.5–1.7 times 
easily than TENS. This indicates that the ICT modality is safer 
and more efficient than the conventional TENS modality due to 
its high penetration efficiency. 
The physiological effectiveness of ICT–TNS for bladder 
function control was demonstrated using preclinical animal 
studies. Cystometry, the conventional bladder-function 
evaluation method with bladder pressure and voiding volume 
of urine, continuously monitored and featured the bladder 
contraction (urination) moments after the ICT–TNS [36-38]. 
The results shown in Fig. 9 and 10 statistically verify the 
bladder activity changes after the ICT–TNS, as bladder 
contraction frequency decreased and voiding volume increased. 
These results indicate that the low-frequency envelope of ICT 
successfully inhibited the bladder activity and controlled the 
function by increasing bladder capacity and decreasing 
urination frequency. 
In addition, by comparing the clinical performance of 
ICT–TNS with that of conventional TENS–TNS, ICT–TNS 
showed similar or same effectiveness in treating bladder 
contraction and voiding volume compared with TENS–TNS 
(Fig. 12). This performance on bladder control by ICT–TNS 
shows the physiological effectiveness of ICT–TNS for OAB 
therapy by relieving its representative symptoms of bladder 
capacity decrease and the subsequent urinary urgency. 
Therefore, the clinical potential of ICT–TNS for OAB 
treatment can be proposed owing to its superiority on high 
penetration efficiency as well as the good physiological 
effectiveness from the preclinical study results. 
Despite its clinical potential, it is important to acknowledge 
that future studies may be required for improving the proposed 
modality by optimizing the ICT stimulation parameters. 
Adjusting ICT-related parameters, such as electrode 
positioning and carrier frequency, is expected to optimize the 
penetration depth and focusing region of ICT for TNS in OAB 
therapy. Particularly, the optimization for electrode placement 
is expected to increase the focusing and targeting ability of 
ICT–TNS for maximizing the tibial nerve recruitment. The in 
silico experiment results (Fig. 7 and 13) confirm the potential 
for the optimization because the focused ICT electric field is 
not maximized at the tibial nerve. Further, the optimization 
should consider the electrode placement that is least influenced 
by anatomical heterogeneity for the real world clinical 
application because such heterogeneity results in the variances 
of the target location and focusing resolution. Moreover, the 
optimization of ICT–TNS could prevent the side effects of TNS 
itself, such as passive leakage presented in Fig. 11, which is 
expected due to sphincter dysfunction. Therefore, future studies 
are required to evaluate the different effectiveness of ICT 
according to the various electrode placements. 
Preclinical studies encompassing larger and more 
human-like animals, such as porcine and canine subjects, may 
strengthen the clinical effectiveness of the ICT. Even based on 
its clinical safety and experimental ease, clinical studies with 
human volunteers could be considered for future research 
because ICT–TNS is noninvasive and has no severe side effects, 
thereby being sufficiently safe for human studies. 
In conclusion, this study proposes a new modality for 
noninvasive TNS using time interfering current method called 
ICT, increasing the field penetration efficiency of TNS, thereby 
preventing the side effects of conventional TENS–TNS. 
Computational analysis with electromagnetic biomedical 
modeling demonstrated the increased field penetration 
efficiency of TNS by applying ICT. In vivo animal experiments 
proved the superior penetration efficiency of ICT–TNS via the 
lower stimulation threshold of ICT than TENS as well as 
proved the good physiological effectiveness of ICT–TNS in 
terms of the bladder inhibition compared with the clinical 
performance of TENS–TNS. Therefore, ICT method is 
expected to be applied in several other noninvasive peripheral 
nerve stimulation therapies as well as TNS to treat OAB. 
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